Abstract
Increasing evidence of the pathological roles of multiple cytokines in orchestrating and perpetuating inflammation in asthma has prompted the evaluation of novel anti-cytokine therapies. Anti-IL-5 antibody markedly reduces peripheral blood and airway eosinophils, but does not appear to be effective in symptomatic asthma. Inhibition of IL-4, despite promising early results in asthma has been discontinued and blocking IL-13 might be more effective. Inhibitory cytokines, such as IL-10, interferons and IL-12 are less promising, as systemic delivery produces side effects. Inhibition of TNF-alpha may be useful in severe asthma. Agents that target IL-13 are still early in the development process. Many chemokines are involved in the inflammatory response of asthma and several small molecule inhibitors of chemokine receptors are in development. CCR3 antagonists, which block eosinophil chemotaxis, are in clinical development for asthma therapy. Because so many cytokines are involved in asthma, drugs that inhibit the synthesis of multiple cytokines may prove to be more useful; several such classes of drug are now in clinical development and any risk of side effects with these non-specific inhibitors may be reduced by the inhaled route.
Citations
Nov 1, 2008·Pharmaceutical Research·Yulia VugmeysterXin Xu
Jun 22, 2005·The Journal of Experimental Medicine·Joshua A Boyce, K Frank Austen
Sep 19, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mohamed Labib SalemDavid J Cole
Oct 26, 2007·Acta Pharmacologica Sinica·Kai WangHua-qiong Huang
Jul 19, 2005·Cancer Research·Judith SchwartzbaumMaria Feychting
Apr 15, 2006·American Journal of Respiratory and Critical Care Medicine·Takumi KiwamotoKiyohisa Sekizawa
Feb 10, 2007·American Journal of Respiratory and Critical Care Medicine·Ariel MunitzFrancesca Levi-Schaffer
Mar 10, 2008·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Masakazu Ichinose
Mar 25, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chih-Cheng ChuangWen-Yuan Du
Jun 14, 2005·Expert Opinion on Therapeutic Targets·Ruo-Pan HuangRuochun Huang
Mar 6, 2013·Experimental Parasitology·Chih-Cheng ChuangWen-Yuan Du
Jun 8, 2011·European Journal of Pharmacology·Hossein SadeghiArdeshir Talebi
May 1, 2010·International Immunopharmacology·Rama MalaviyaRavi Malaviya
Feb 20, 2007·European Journal of Pharmacology·Taiji YoshinoToshimitsu Yamada
Mar 1, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C HerbertR K Kumar
Nov 6, 2009·Acta Tropica·Chih-Cheng ChuangWen-Yuan Du
Feb 7, 2006·European Journal of Pharmacology·Toshiyuki Yamagata, Masakazu Ichinose
Oct 1, 2013·Experimental Parasitology·Wen-Yuan DuChih-Cheng Chuang
Nov 15, 2011·Acta Tropica·Jun-Jian LiZhong Hu
Dec 17, 2005·Current Opinion in Pulmonary Medicine·Esteban J Morcillo, Julio Cortijo